Showing results (1-10 of 199) with videos related to
Sort By:
Pageof 20
Gut|June 14, 2005
Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosisE Albano, E Mottaran, M Vidali, et al.Cardiology|January 1, 1990
Current application of implantable cardioverter-defibrillators in the management of malignant ventricular tachyarrhythmiasS SaksenaPacing and Clinical Electrophysiology : PACE|January 1, 1993
Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. The PCD investigators and participating institutionsS SaksenaAmerican Heart Journal|April 1, 1994
The impact of implantable cardioverter defibrillator therapy on health care systemsS SaksenaClinics in Liver Disease|August 28, 2004
The potential role of genes in nonalcoholic fatty liver diseaseC P DayBest Practice & Research. Clinical Gastroenterology|October 31, 2002
Pathogenesis of steatohepatitisC P DayJournal of the Royal College of Physicians of London|February 24, 2001
Who gets alcoholic liver disease: nature or nurture?C P DayJournal of the Royal College of Physicians of London|May 1, 1994
Alcohol--risks and mechanisms of damageC P DayPostgraduate Medicine|June 1, 1986
Tachyarrhythmias. Application of new information to clinical managementS Saksena, A GadhokeAmerican Heart Journal|January 1, 1987
Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisalD Lavery, S SaksenaPageof 20